Home > QualityStocks Stock Newsletters > Page 236

Category: QualityStocks Stock Newsletters

MondayMay 09, 2011 1:23 pm

Bacterin International Holdings Inc. (BONE) to Begin Distribution of Its Third Biological Scaffold

Bacterin International Holdings Inc. is the developer of revolutionary bone graft material and antimicrobial coatings for a number of medical applications. The company's proprietary methods optimize the growth factors in human allografts to create the ideal stem cell scaffold and promote bone and other tissue growth. The company announced recently that it is commencing distribution of Bacterin's third human acellular biological scaffold, hMatrix, an acellular dermal scaffold. It is an acellular matrix processed from donated human dermal tissue that is used to replace damaged tissue or repair, reinforce or support soft tissue defects. hMatrix retains the natural structure of dermis…

Continue Reading

MondayMay 09, 2011 1:17 pm

Hondo Minerals Corp. (HMNC) Reports Update on Tennessee Property

Hondo Minerals Corp. issued an updated review on its mining activities at its properties in the United States, where the company is actively prospecting for gold, silver and other metals. Hondo Minerals reported that it has signed a purchase agreement for processing equipment in the amount of $2.4 million. The company estimates that the equipment has a fair market value of $4 million. Hondo Minerals said that the equipment is slated for use at the Tennessee Mine facility where the company is targeting gold, silver and zinc. The equipment will enable Hondo Minerals to process between ten and twenty tons…

Continue Reading

MondayMay 09, 2011 11:23 am

Star Scientific, Inc. (CIGX) Video Chart for Monday, May 9, 2011

CIGX is putting together a new uptrend since pulling back from its April highs in excess of $5 per share. The indicators are aligning and the chart is hitting our watchlist for continuation. To view the video chart, visit the following link: http://www.qualitystocks.net/videocharts.php Let us hear your thoughts below:

Continue Reading

MondayMay 09, 2011 8:41 am

NovaBay Pharmaceuticals Inc. (NBY) Showcases 3 New Biotech Compounds at Florida Ophthalmology Conference

NovaBay Pharmaceuticals Inc., a clinical-stage biotech company developing compounds to fight bacteria, fungi and viruses, presented a poster at the 2011 Conference of the Association for Research in Vision and Ophthalmology (ARVO) held this week in Fort Lauderdale, Fla. The poster, titled “Aganocide® Compounds Effective Against Ophthalmic Pathogens,” highlights three new Aganocide compounds similar to NovaBay’s lead anti-infective Aganocide compound, NVC-422. Novabay’s NVC-727, NVC-638, and NVC-704 compounds are broad-spectrum, fast-acting antimicrobial agents designed with the same mechanism of action but different activity profiles. The three new compounds expand Novabay’s current portfolio of Aganocide compounds and open a door for the…

Continue Reading

MondayMay 09, 2011 8:40 am

PhotoMedex, Inc. (PHMD) Introduces DNA Damage Control Product

PhotoMedex, Inc., an industry leader of clinical skincare and laser products, introduced their innovative DNA Damage Control product. This product is much different than typical treatments and sunscreens in that it uses DNA to repair damaged skin. This product is being marketed under the company's NEOVA brand. DNA Damage Control defends against photodamage by boosting the body’s natural DNA repair process. The patent-pending formulas use liposomes to deliver DNA repair enzymes to the cellular level of the skin, hyper-targeting the site of the DNA injury. Clinical studies have shown that DNA repair enzymes reduced DNA damage by 45% and increased…

Continue Reading

MondayMay 09, 2011 8:38 am

DUSA Pharmaceuticals Inc. (DUSA) Posts 27% Hike in Q1 Earnings

DUSA Pharmaceuticals Inc., a dermatology company developing and marketing products focused on patients with common skin conditions, Friday posted its first-quarter financials, reporting a 27 percent earnings increase. Revenues for the first quarter of 2011 were $11.1 million, up 27 percent compared to $8.7 million reported for the comparable quarter of 2010. The company widened its net loss for the quarter at $0.6 million, or $(0.02) per common share, compared to a net loss of $0.4 million, or ($0.02) per common share, in the first quarter of the year prior. As of March 31, 2011, the company had total cash,…

Continue Reading

MondayMay 09, 2011 8:25 am

EcoEmissions Solutions, Inc. (ECMZ) Spammed Aggressively over Weekend

We have observed an influx of emails spamming EcoEmissions Solutions, Inc. from various free email accounts over the weekend. Investors should be wary of these emails, as they are completely anonymous and violate the CAN-SPAM Act established by the FTC. As of this time, the company has not provided a public comment on the issue. Stocks to avoid, due diligence, monitoring investments, key terms in investing and other related topics are covered by us in our Market Basics section. Here we give answers to basic questions regarding stock investments for both new and experienced investors. To view our Market Basics…

Continue Reading

FridayMay 06, 2011 10:25 pm

Solta Medical, Inc. (SLTM) Receives 501k Clearance from FDA for Clear + Brilliant Treatment

Solta Medical reported today reception of FDA 501k clearance for the Company’s Clear + Brilliant treatment, which had previously received CE mark and is based on SLTM’s fractional laser technology. The Clear + Brilliant treatment will be officially launched at the upcoming World Congress of Dermatology in Seoul, Korea. The advent of this new treatment would not have been possible without the Company’s mastery of fractional laser applications, as evident in SLTM’s Fraxel® treatment, which delivers minimally invasive clinical solutions for resurfacing aging/sun damaged skin. The Company started shipping the product to select/key international markets back in April and has…

Continue Reading

FridayMay 06, 2011 10:25 pm

SinoTech Energy Ltd. (CTE) Raises Expectations for Fiscal Year 2011

Located in China, SinoTech has rapidly evolved as a provider of enhanced oil recovery (“EOR”) services. Today, the company announced an updated financial outlook for fiscal year 2011. SinoTech also told investors that it will release its unaudited financial results for the second quarter ended March 31, 2011, on May 19, 2011. Based on current business and operating conditions, SinoTech expects to report total sales in the range of US$100 million to US$105 million in fiscal year 2011. The numbers greatly exceed the previously announced range of US$90 million to US$95 million. Leading the way at SinoTech is Mr. Boxun…

Continue Reading

FridayMay 06, 2011 10:25 pm

DUSA Pharmaceuticals (DUSA) Posts Higher Earnings, Wider Net Loss

DUSA Pharmaceuticals Inc., a dermatology company that is developing and marketing Levulan® Photodynamic Therapy (PDT) and other products focused on patients with common skin conditions, reported a 27 percent increase in first-quarter revenues. “We are off to a great start in 2011,” Robert Doman, president and CEO of the DUSA stated in the press release. “Continued growth of our core domestic PDT revenues, as well as record gross margins, drove significant year-over-year improvement in our non-GAAP profitability and cash flow.” Total product revenues for the first quarter were $11.1 million, up 27 percent from $8.7 million in the first quarter…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered

512.354.7000

Please read Disclaimers for FULL Compensation Disclosures and other disclaimers.

Copyright © .